ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2053

Mortality Decreases in Patients with Rheumatoid Arthritis: a 15-Year Prospective Cohort Study

Joëlle van den Hoek1,2, Hendriek C. Boshuizen3, Leo D. Roorda4, Gerard J. Tijhuis5, Mike T. Nurmohamed5, Trudi van den Bos2 and Joost Dekker6,7, 1Rehabilitation Research Center, Reade, Rehabilitation | Rheumatology, Amsterdam, Netherlands, 2Social Medicine, Academic Medical Center, Amsterdam, Netherlands, 3National Institute of Public Health and the Environment, Bilthoven, Netherlands, 4Amsterdam Rehabilitation Research Center | Reade, Amsterdam, the Netherlands, Amsterdam, Netherlands, 5Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, 6Rehabilitation Medicine, Psychiatry and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, Netherlands, 7Reade, centre for Rehabilitation and Rheumatology, Amsterdam, Netherlands

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: death, longitudinal studies, morbidity and mortality and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Public Health (ARHP)

Session Type: Abstract Submissions (ARHP)

Background/Purpose

Patients with rheumatoid arthritis (RA) have a higher mortality risk than the general population, with similar patterns over the last decades. However, more recent studies show conflicting results. Given these conflicting results, there is an obvious need to evaluate the risk of mortality in patients with RA, over a long period, using more recent mortality data.

Objectives

To investigate a) the mortality in a clinical cohort of patients with established rheumatoid arthritis in comparison with the general Dutch population over 15 years, b) the trend in the mortality ratio during the study period, and c) the causes of death and compare these with the general population.

Methods

In 1997, a sample of 1222 patients was randomly selected from the register of a large rheumatology outpatient clinic in Amsterdam. Their mortality and causes of death between 1997 and 2012 were obtained from Statistics Netherlands. The Standardized Mortality Ratio (SMR) for all-cause mortality and the number of life-years lost in the study period were calculated. Linear poisson regression analysis was performed to evaluate change in all-cause SMR over time. Finally, the SMRs for cause-specific mortality were calculated.

Results

The mean age of the population at baseline was 60.4 (SD 15.4) years and 72.6% of the patients were women. The estimated SMR (95% CI) for all-cause mortality was 1.54 (1.41, 1.67) with about one life-year lost over the study period. The SMR decreased with 2% annually (p = .05). Mortality increased for diseases of the circulatory system, respiratory system, musculoskeletal system, and digestive system (p < .05).

Conclusion

The observed mortality among patients with RA was more than 50% higher than in the general population. More than one life-year was lost over 15 years and the mortality seemed to decrease over time. The most frequent causes of death were the same as those in the general population.

Annual Standardized Mortality Ratio and 95% Confidence Interval.


Disclosure:

J. van den Hoek,
None;

H. C. Boshuizen,
None;

L. D. Roorda,
None;

G. J. Tijhuis,
None;

M. T. Nurmohamed,
None;

T. van den Bos,
None;

J. Dekker,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mortality-decreases-in-patients-with-rheumatoid-arthritis-a-15-year-prospective-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology